Bioventus Inc.
BVS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $568M | $573M | −0.9% |
| Operating income | $54.0M | −$15.2M | |
| Net income | $22.7M | −$36.1M |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 26, 2026 · filed Nov 2, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $142M | $139M | +2.7% |
| Operating income | $9.70M | $11.3M | −14.2% |
| Net income | $6.00M | $3.20M | +87.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Bioventus's revenue in FY2025?
- $568M in FY2025 (Fiscal year ended Dec 31, 2025), −0.9% vs $573M a year earlier, per its 10-K filed Mar 2026.
- Was Bioventus profitable in FY2025?
- Yes: net income was $22.7M and operating income $54.0M in FY2025.
- What was Bioventus's revenue in Q3 2026?
- $142M (+2.7% vs a year earlier), per its Form 10-Q filed Nov 2, 2026.